Semaglutide Safety Profile
Safety information for semaglutide including common side effects, warnings, and contraindications.
Last updated: January 19, 2026
For Educational Purposes Only
This safety information is compiled from clinical trial data and regulatory documents for educational purposes. It is not a substitute for professional medical advice. Always consult your healthcare provider about medication safety, especially regarding your individual circumstances, medical history, and other medications.
Safety Overview
Semaglutide has been extensively studied in clinical trials involving tens of thousands of patients. It has an established safety profile with known side effects.
Common Side Effects
| Side Effect | Frequency | Notes |
|---|---|---|
| Nausea | 15-20% | Usually improves over time |
| Diarrhea | 8-12% | May decrease with continued use |
| Vomiting | 5-10% | More common during dose escalation |
| Constipation | 5-8% | Variable |
| Abdominal pain | 5-8% | Usually transient |
Serious Warnings
Boxed Warning: Thyroid C-Cell Tumors
Based on rodent studies, there is a theoretical risk of thyroid tumors. Monitor for thyroid nodules or symptoms.
Other Serious Risks
- Pancreatitis — Discontinue if suspected
- Gallbladder disease — Increased risk with rapid weight loss
- Diabetic retinopathy — May worsen initially with rapid glucose improvement
- Kidney injury — Usually related to dehydration from GI effects
Who Should NOT Use Semaglutide
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known hypersensitivity to semaglutide
- History of serious hypersensitivity reaction to any GLP-1 agonist
Drug Interactions
- May affect absorption of oral medications (delayed gastric emptying)
- Increased hypoglycemia risk with insulin or sulfonylureas
- Consult healthcare provider about all medications
Monitoring Recommendations
- Regular blood glucose monitoring (in diabetes)
- Watch for signs of pancreatitis
- Monitor for gallbladder symptoms
- Eye exams for diabetic patients
This safety information is for educational purposes. Consult the full prescribing information and your healthcare provider.
Safety Alerts
Get notified about new safety data, FDA decisions, and adverse event reports.
No spam. Unsubscribe anytime.
Important: Safety information evolves as post-marketing data accumulates. This page reflects data available as of the last update date. Check official FDA and EMA resources for the most current safety information. This content is not intended to diagnose, treat, cure, or prevent any disease.